PLAUR and hydrops fetalis: Soluble urokinase plasminogen activator receptor in the acute and post-ACS convalescent conferred additional hazard for the composite endpoint of HF/death (HR > 1.4), HF (HR > 1.3), and death (HR > 1.2) after adjustment for risk factors including circulating cardiac markers.